ACADIA PHARMACEUTICALS INC. Other Revenue, Net (Deprecated 2018-01-31)
ACADIA PHARMACEUTICALS INC. (ACAD) reported Other Revenue, Net (Deprecated 2018-01-31) of $4.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-02-27
- ACADIA PHARMACEUTICALS INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $4.00K.
- ACADIA PHARMACEUTICALS INC. other revenue, net (deprecated 2018-01-31) for fiscal 2016 was $4.00K, a 93.44% decline from fiscal 2015.
- ACADIA PHARMACEUTICALS INC. other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $61.00K, a 49.17% decline from fiscal 2014.
- ACADIA PHARMACEUTICALS INC. other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $120.00K.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $4.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $4.00K 10-Q · filed 2017-11-07 | $21.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $4.00K 10-Q · filed 2017-08-08 | $21.00K derived: sum of 3 quarters · filed 2018-02-27 | $60.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $4.00K 10-Q · filed 2017-05-09 | $21.00K derived: sum of 2 quarters · filed 2018-02-27 | $60.00K derived: sum of 3 quarters · filed 2018-02-27 | $61.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $56.00K derived: sum of 2 quarters · filed 2018-02-27 | $57.00K derived: sum of 3 quarters · filed 2018-02-27 | $61.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $39.00K 10-Q · filed 2016-11-07 | $40.00K derived: sum of 2 quarters · filed 2016-11-07 | $44.00K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $1.00K 10-Q · filed 2016-08-04 | $5.00K 10-Q · filed 2016-08-04 | ||
| 2014-12-31 | $120.00K 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |